Citeline presents a tool to support the diversification of clinical trials
It allows medical decisions to be made based on patient demographics.
Stay updated with breaking news from Diversity Module. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It allows medical decisions to be made based on patient demographics.
NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) -- With new Food and Drug Administration (FDA) guidance, study sponsors are no longer viewing clinical trial diversity as "nice to have" but as a "must have." Citeline's
Intelligent Trials Diversity Module Addresses Critical Need to Increase Study Access and Engagement Medidata, a Dassault Systèmes company, has launched the Intelligent Trials Diversity Module to
The panel will showcase how corporate law departments are using AI to improve compliance and outside counsel management Fresh from celebrating the five-year anniversary of its AI-powered LegalVIEW